Arenicin-1 vs REGN1033
Head-to-head comparison of Arenicin-1 (Arenicin-1) and REGN1033 (Trevogrumab (REGN1033)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | REGN1033 |
|---|---|---|
| Category | Marine-Derived | Muscle & Performance |
| Full Name | Arenicin-1 | Trevogrumab (REGN1033) |
| Molecular Weight | 2079 Da | ~150 kDa |
| Half-Life | n/a | ~2-3 weeks |
| Amino Acids | 21 | N/A |
| Typical Dose | n/a | 100-300 mg SC or equivalent trial dosing |
| Route | preclinical | Subcutaneous / Intravenous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 60 |
| Research Status | Pre-clinical | Clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
REGN1033 Benefits
- ✓myostatin blockade
- ✓lean-mass preservation
- ✓muscle hypertrophy support
- ✓catabolic-state countermeasure
Arenicin-1 Dosing
bacterial infection|biofilm disruption
REGN1033 Dosing
SC or IV clinical-trial dosing|repeat every 2-4 weeks|dose escalation by study
Arenicin-1 Side Effects
- ⚠Arenicola marina
REGN1033 Side Effects
- ⚠injection-site reactions
- ⚠headache
- ⚠fatigue
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
REGN1033
Human and animal studies indicate that myostatin neutralization can increase muscle size, though functional gains are often smaller than mass gains. Trevogrumab is part of the broader literature showing that selective myostatin inhibition can alter body composition in clinically meaningful ways.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.